$BMRN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in BIOMARIN PHARMACEUTICAL INC. Get notifications about new insider transactions in BIOMARIN PHARMACEUTICAL INC for free.

Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 34 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 04 2018	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Option Exercise	M	38.59	3,750	144,713	3,750
Jan 04 2018	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Sell	S	88.84	3,750	333,150	14,860	18.6 K to 14.9 K (-20.15 %)
Jan 04 2018	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Buy	M	38.59	3,750	144,713	18,610	14.9 K to 18.6 K (+25.24 %)
Jan 04 2018	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Option Exercise	M	37.46	10,000	374,600	27,331
Jan 04 2018	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Option Exercise	M	26.49	5,000	132,450	5,225
Jan 04 2018	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Sell	S	89.23	15,000	1,338,401	133,976	149 K to 134 K (-10.07 %)
Jan 04 2018	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Buy	M	37.46	10,000	374,600	148,976	139 K to 149 K (+7.20 %)
Jan 04 2018	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Buy	M	26.49	5,000	132,450	138,976	134 K to 139 K (+3.73 %)
Jan 02 2018	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	38.59	10,000	385,900	192,500
Jan 02 2018	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	38.59	10,000	385,900	202,500
Jan 02 2018	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	89.61	10,000	896,125	225,894	235.9 K to 225.9 K (-4.24 %)
Jan 02 2018	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	38.59	10,000	385,900	235,894	225.9 K to 235.9 K (+4.43 %)
Jan 02 2018	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	89.89	10,000	898,912	225,894	235.9 K to 225.9 K (-4.24 %)
Jan 02 2018	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	38.59	10,000	385,900	235,894	225.9 K to 235.9 K (+4.43 %)
Jan 02 2018	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Gift	G	0.00	600	0	225,894	226.5 K to 225.9 K (-0.26 %)
Jan 02 2018	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Gift	G	0.00	430	0	226,494	226.9 K to 226.5 K (-0.19 %)
Dec 18 2017	BMRN	BIOMARIN PHARMACEU ...	HERON ELAINE J	Director	Sell	S	88.90	800	71,116	38,385	39.2 K to 38.4 K (-2.04 %)
Dec 04 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Sell	S	85.64	1,200	102,767	82,942	84.1 K to 82.9 K (-1.43 %)
Oct 03 2017	BMRN	BIOMARIN PHARMACEU ...	HOMBACH ROBERT J.	Director	Grant	A	0.00	3,180	0	3,180	0 to 3.2 K
Oct 02 2017	BMRN	BIOMARIN PHARMACEU ...	BAFFI ROBERT	EVP, Technical Oper ...	Sell	S	92.06	2,915	268,355	28,761	31.7 K to 28.8 K (-9.20 %)
Oct 02 2017	BMRN	BIOMARIN PHARMACEU ...	BAFFI ROBERT	EVP, Technical Oper ...	Sell	S	92.50	15,500	1,433,676	129,083	144.6 K to 129.1 K (-10.72 %)
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	37.46	2,166	81,138	0
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	37.46	1,355	50,758	2,166
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	95.00	2,166	205,770	47,944	50.1 K to 47.9 K (-4.32 %)
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	37.46	2,166	81,138	50,110	47.9 K to 50.1 K (+4.52 %)
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	95.00	1,355	128,725	47,944	49.3 K to 47.9 K (-2.75 %)
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	37.46	1,355	50,758	49,299	47.9 K to 49.3 K (+2.83 %)
Sep 19 2017	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Option Exercise	M	38.59	3,750	144,713	7,500
Sep 19 2017	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Sell	S	91.26	3,750	342,225	15,910	19.7 K to 15.9 K (-19.07 %)
Sep 19 2017	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Buy	M	38.59	3,750	144,713	19,660	15.9 K to 19.7 K (+23.57 %)
Sep 19 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Option Exercise	M	37.46	10,000	374,600	37,934
Sep 19 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Option Exercise	M	26.49	5,000	132,450	10,225
Sep 19 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Sell	S	90.50	15,000	1,357,500	136,422	151.4 K to 136.4 K (-9.91 %)
Sep 19 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Buy	M	37.46	10,000	374,600	151,422	141.4 K to 151.4 K (+7.07 %)
Sep 19 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Buy	M	26.49	5,000	132,450	141,422	136.4 K to 141.4 K (+3.67 %)
Jun 27 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Option Exercise	M	38.59	9,844	379,880	30,000
Jun 27 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Sell	S	96.60	9,844	950,930	83,581	93.4 K to 83.6 K (-10.54 %)
Jun 27 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Buy	M	38.59	9,844	379,880	93,425	83.6 K to 93.4 K (+11.78 %)
Jun 23 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Option Exercise	M	21.51	2,671	57,453	0
Jun 23 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Sell	S	100.00	2,671	267,100	12,885	15.6 K to 12.9 K (-17.17 %)
Jun 23 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Buy	M	21.51	2,671	57,453	15,556	12.9 K to 15.6 K (+20.73 %)
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Option Exercise	M	37.46	603	22,588	47,331
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Option Exercise	M	37.46	9,397	352,012	47,934
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Option Exercise	M	26.49	5,000	132,450	15,225
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Sell	S	90.00	603	54,270	136,422	137 K to 136.4 K (-0.44 %)
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Buy	M	37.46	603	22,588	137,025	136.4 K to 137 K (+0.44 %)
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Sell	S	90.00	9,397	845,730	136,422	145.8 K to 136.4 K (-6.44 %)
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Sell	S	90.00	5,000	450,000	145,819	150.8 K to 145.8 K (-3.32 %)
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Buy	M	37.46	9,397	352,012	150,819	141.4 K to 150.8 K (+6.64 %)
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Buy	M	26.49	5,000	132,450	141,422	136.4 K to 141.4 K (+3.67 %)
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Option Exercise	M	38.59	3,750	144,713	11,250
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Sell	S	90.00	3,750	337,500	15,910	19.7 K to 15.9 K (-19.07 %)
Jun 20 2017	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Buy	M	38.59	3,750	144,713	19,660	15.9 K to 19.7 K (+23.57 %)
Jun 13 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Option Exercise	M	26.49	3,775	100,000	0
Jun 13 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Option Exercise	M	21.51	5,464	117,531	0
Jun 13 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Buy	M	26.49	3,775	100,000	83,581	79.8 K to 83.6 K (+4.73 %)
Jun 13 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Buy	M	21.51	5,464	117,531	79,806	74.3 K to 79.8 K (+7.35 %)
Jun 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	89.61	1,004	89,968	47,944	48.9 K to 47.9 K (-2.05 %)
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Option Exercise	A	89.60	4,910	439,936	4,910
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	LAWLIS V BRYAN	Director	Grant	A	0.00	2,050	0	15,910	13.9 K to 15.9 K (+14.79 %)
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	PYOTT DAVID E I	Director	Option Exercise	A	89.60	4,910	439,936	4,910
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	PYOTT DAVID E I	Director	Grant	A	0.00	2,050	0	4,910	2.9 K to 4.9 K (+71.68 %)
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	Slamon Dennis	Director	Option Exercise	A	89.60	4,910	439,936	4,910
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	Slamon Dennis	Director	Grant	A	0.00	2,050	0	9,885	7.8 K to 9.9 K (+26.16 %)
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	LEWIS ALAN	Director	Option Exercise	A	89.60	4,910	439,936	4,910
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	LEWIS ALAN	Director	Grant	A	0.00	2,050	0	26,060	24 K to 26.1 K (+8.54 %)
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	GREY MICHAEL G	Director	Option Exercise	A	89.60	4,910	439,936	4,910
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	GREY MICHAEL G	Director	Grant	A	0.00	2,050	0	29,810	27.8 K to 29.8 K (+7.38 %)
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	HERON ELAINE J	Director	Option Exercise	A	89.60	4,910	439,936	4,910
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	HERON ELAINE J	Director	Grant	A	0.00	2,050	0	39,185	37.1 K to 39.2 K (+5.52 %)
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	MEIER RICHARD A	Director	Option Exercise	A	89.60	4,910	439,936	4,910
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	MEIER RICHARD A	Director	Grant	A	0.00	2,050	0	36,310	34.3 K to 36.3 K (+5.98 %)
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	Dere Willard H	Director	Option Exercise	A	89.60	4,910	439,936	4,910
Jun 08 2017	BMRN	BIOMARIN PHARMACEU ...	Dere Willard H	Director	Grant	A	0.00	2,050	0	4,690	2.6 K to 4.7 K (+77.65 %)
Jun 07 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Sell	S	91.04	9,471	862,230	74,342	83.8 K to 74.3 K (-11.30 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	SPIEGELMAN DANIEL K	EVP, Chief Financia ...	Payment of Exercise	F	90.72	1,801	163,387	23,303	25.1 K to 23.3 K (-7.17 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Payment of Exercise	F	90.72	376	34,111	12,885	13.3 K to 12.9 K (-2.84 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Payment of Exercise	F	90.72	2,036	184,706	136,422	138.5 K to 136.4 K (-1.47 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	90.72	1,488	134,991	48,948	50.4 K to 48.9 K (-2.95 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	BAFFI ROBERT	EVP, Technical Oper ...	Payment of Exercise	F	90.72	1,644	149,144	144,583	146.2 K to 144.6 K (-1.12 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Payment of Exercise	F	90.72	1,488	134,991	83,813	85.3 K to 83.8 K (-1.74 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	0
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	5,000
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	90.56	5,000	452,800	226,924	231.9 K to 226.9 K (-2.16 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	231,924	226.9 K to 231.9 K (+2.20 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Payment of Exercise	F	90.72	6,640	602,381	226,924	233.6 K to 226.9 K (-2.84 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	89.70	5,000	448,500	233,564	238.6 K to 233.6 K (-2.10 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	238,564	233.6 K to 238.6 K (+2.14 %)
Jun 05 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	10,000
Jun 05 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	87.53	5,000	437,650	233,564	238.6 K to 233.6 K (-2.10 %)
Jun 05 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	238,564	233.6 K to 238.6 K (+2.14 %)
Jun 02 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	7,423	128,641	15,000
Jun 02 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	88.29	7,423	655,377	233,564	241 K to 233.6 K (-3.08 %)
Jun 02 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	7,423	128,641	240,987	233.6 K to 241 K (+3.18 %)
May 26 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	22,423
May 26 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	88.38	5,000	441,900	233,564	238.6 K to 233.6 K (-2.10 %)
May 26 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	238,564	233.6 K to 238.6 K (+2.14 %)
May 19 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	27,423
May 19 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	91.73	5,000	458,650	233,564	238.6 K to 233.6 K (-2.10 %)
May 19 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	238,564	233.6 K to 238.6 K (+2.14 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Option Exercise	M	14.39	1,146	16,491	0
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Buy	M	14.39	1,146	16,491	85,301	84.2 K to 85.3 K (+1.36 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Payment of Exercise	F	91.50	1,096	100,284	84,155	85.3 K to 84.2 K (-1.29 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Payment of Exercise	F	91.50	207	18,941	13,261	13.5 K to 13.3 K (-1.54 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Payment of Exercise	F	91.50	4,932	451,278	233,564	238.5 K to 233.6 K (-2.07 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	SPIEGELMAN DANIEL K	EVP, Chief Financia ...	Payment of Exercise	F	91.50	1,722	157,563	25,104	26.8 K to 25.1 K (-6.42 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	SPIEGELMAN DANIEL K	EVP, Chief Financia ...	Grant	A	70.30	155	10,897	26,826	26.7 K to 26.8 K (+0.58 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Payment of Exercise	F	91.50	2,036	186,294	138,458	140.5 K to 138.5 K (-1.45 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	FUCHS HENRY J	President, Worldwid ...	Grant	A	70.30	302	21,232	140,494	140.2 K to 140.5 K (+0.22 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	BAFFI ROBERT	EVP, Technical Oper ...	Payment of Exercise	F	91.50	1,566	143,289	146,227	147.8 K to 146.2 K (-1.06 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	BAFFI ROBERT	EVP, Technical Oper ...	Grant	A	70.30	302	21,232	147,793	147.5 K to 147.8 K (+0.20 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	91.50	1,096	100,284	50,436	51.5 K to 50.4 K (-2.13 %)
May 16 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	32,423
May 16 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	89.23	5,000	446,150	238,496	243.5 K to 238.5 K (-2.05 %)
May 16 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	243,496	238.5 K to 243.5 K (+2.10 %)
May 10 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Option Exercise	M	21.51	2,600	55,926	2,671
May 10 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Sell	S	93.17	2,600	242,242	13,468	16.1 K to 13.5 K (-16.18 %)
May 10 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Buy	M	21.51	2,600	55,926	16,068	13.5 K to 16.1 K (+19.31 %)
May 10 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Sell	S	91.17	4,882	445,092	13,468	18.4 K to 13.5 K (-26.60 %)
May 10 2017	BMRN	BIOMARIN PHARMACEU ...	Mueller Brian	SVP, Corporate Cont ...	Grant	A	70.30	270	18,982	18,350	18.1 K to 18.4 K (+1.49 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	MEIER RICHARD A	Director	Option Exercise	M	17.33	7,500	129,975	0
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	MEIER RICHARD A	Director	Buy	M	17.33	7,500	129,975	34,260	26.8 K to 34.3 K (+28.03 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	38.59	3,498	134,988	0
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	28.23	988	27,891	0
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	99.00	3,498	346,302	51,532	55 K to 51.5 K (-6.36 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	38.59	3,498	134,988	55,030	51.5 K to 55 K (+6.79 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	99.00	988	97,812	51,532	52.5 K to 51.5 K (-1.88 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	28.23	988	27,891	52,520	51.5 K to 52.5 K (+1.92 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Option Exercise	M	38.59	2,500	96,475	39,844
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Sell	S	100.34	2,500	250,853	85,251	87.8 K to 85.3 K (-2.85 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Buy	M	38.59	2,500	96,475	87,751	85.3 K to 87.8 K (+2.93 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Davis George Eric	EVP, General Counse ...	Grant	A	70.30	302	21,232	85,251	84.9 K to 85.3 K (+0.36 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	37,423
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	42,423
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	93.17	5,000	465,850	238,496	243.5 K to 238.5 K (-2.05 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	243,496	238.5 K to 243.5 K (+2.10 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	99.00	5,000	495,000	238,496	243.5 K to 238.5 K (-2.05 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	243,496	238.5 K to 243.5 K (+2.10 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Grant	A	70.30	302	21,232	238,496	238.2 K to 238.5 K (+0.13 %)
May 04 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	96.74	302	29,215	51,532	51.8 K to 51.5 K (-0.58 %)
May 04 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	70.30	302	21,232	51,834	51.5 K to 51.8 K (+0.59 %)
May 01 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	47,423
May 01 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	95.72	5,000	478,600	238,194	243.2 K to 238.2 K (-2.06 %)
May 01 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	243,194	238.2 K to 243.2 K (+2.10 %)
Apr 27 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	17.33	5,000	86,650	52,423
Apr 27 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Sell	S	94.00	5,000	470,000	238,194	243.2 K to 238.2 K (-2.06 %)
Apr 27 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	17.33	5,000	86,650	243,194	238.2 K to 243.2 K (+2.10 %)
Apr 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Option Exercise	M	14.39	3,000	43,170	114,000
Apr 06 2017	BMRN	BIOMARIN PHARMACEU ...	BIENAIME JEAN JACQUES	Chief Executive Off ...	Buy	M	14.39	3,000	43,170	238,194	235.2 K to 238.2 K (+1.28 %)
Mar 31 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	89.15	3,890	346,794	51,532	55.4 K to 51.5 K (-7.02 %)

Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 34 next >